You have searched for ""healthcare""
Showing 41-50 of 6244
NEW YORK: The U.S. healthcare sector looks set for a bulked up profile in growth indexes when FTSE Russell reconstitutes its stock indexes late next Friday, an annual event that historically creates one of the biggest trading volume days of the year.
GENEVA: The coronavirus pandemic is accelerating, with Thursday's 150,000 new cases the highest in a single day and nearly half of those in the Americas, the World Health Organization (WHO) said.
NEW YORK: The S&P 500 ended lower on Friday after an up-and-down session as investors weighed spiking cases of COVID-19 and Apple Inc's announcement of fresh store closures against anticipated stimulus and continued economic recovery.
THE outbreak of Covid-19 has provided fresh opportunities for local entrepreneurs to tap into the logistics market. And Penang-based entrepreneur Chuah Di Ken, 24, is one of those eager to have a slice of the growing pie.
THIS week, global markets were spooked by the re-emergence of Covid-19 cases in places where the deadly virus was seen to be well under control. From Beijing to New York and from Mumbai to Moscow, incidences of Covid-19 are either rising or have reached new record highs as economies begin to open-up.
THE dollar appreciated by 0.10% to 97.40, benefiting from safe-haven flows following rising concerns about a rise in new coronavirus cases; and geopolitical risks – clashes along the India-China border, as well as fresh provocations by North Korea – blowing up a liaison office building it operates with South Korea.
KUALA LUMPUR: Stocks to watch on Thursday include TRC Synergy Bhd, Eversendai Corp Bhd, Sarawak Consolidated Industries Bhd (SCIB) and Duopharma Biotech Bhd, according to JF Apex Research.
Hospital one of first few in country to AI scanner have device
PETALING JAYA: There remains ample room and potential for more syariah-compliant financial companies to list on the Malaysian stock exchange, according to Bursa Malaysia Bhd chairman Tan Sri Abdul Wahid Omar.
KUALA LUMPUR: Duopharma Biotech Bhd plans to implement a four-pronged strategy to expand its consumer healthcare (CHC) product portfolios, diversify into high-value biologicals and niche products, upgrade manufacturing facilities and enhance its Asean presence.